Key result
Fetal growth restriction in neonates is linked to a ~3% lower LVEF versus controls.
Why the study?
To evaluate cardiac structural and functional changes in neonates with fetal growth restriction compared to appropriate-for-gestational-age neonates using conventional echocardiography, TDI, and speckle tracking echocardiography.
Does fetal growth restriction cause subclinical myocardial dysfunction in neonates compared to appropriate-for-gestational-age controls?
Case-Control (n=160)
Does fetal growth restriction cause subclinical myocardial dysfunction in neonates compared to appropriate-for-gestational-age controls?
Absolute Event Rate: 66.14% vs 69.46%
p-value: p=<0.001
Fetal growth restriction is associated with subclinical myocardial dysfunction in neonates, evidenced by reduced left ventricular ejection fraction and global longitudinal strain.
Associated with subclinical LV dysfunction in FGR neonates; hypothesis-generating for long-term outcomes and does not support routine screening.
Objectives To evaluate cardiac structural and functional changes in neonates with fetal growth restriction (FGR) compared to appropriate-for-gestational-age (AGA) neonates using conventional echocardiography, tissue Doppler imaging (TDI), and speckle tracking echocardiography.Method This case-control study included 85 FGR neonates and 75 non-FGR, weight adequate for gestational age neonates. Among these, 37 were symmetric FGR and 48 were asymmetric FGR. All the biophysical profiles of these newborns were assessed. An echocardiographic test was performed to evaluate cardiac dimension, Left ventricular ejection fraction (LV EF), Mitral valve Doppler flow velocities, myocardial performance index, tissue annular velocities, and LV global longitudinal strain (GLS).Results Although LVEF was found to be within the normal range, mean EF was reduced among neonates with FGR than non-FGR controls (EF: 66.14 ± 3.85% vs 69.46 ± 3.58%; p < 0.001, in FGR and non-FGR, respectively). Furthermore, LV E/E’ a measure of LV diastolic function was altered among both types of FGR neonates. Similarly, LV GLS was reduced among FGR neonates (LV GLS: −20.69 ± 2.7% vs −19.06 ± 2.9%; p < 0.001 in non-FGR and FGR, respectively).Conclusion FGR neonates exhibit significant alterations in cardiac geometry compared to AGA controls. FGR neonates also demonstrated a significant reduction in LV EF, FS, and LV global longitudinal strain, depicting failure to adapt to the increased cardiac workload after birth.
No takes yet. Share an insight, caveat, or question.
Ashwal et al. (2024) conducted a case-control in Fetal growth restriction (n=160). Fetal growth restriction vs. Appropriate-for-gestational-age (AGA) was evaluated on Left ventricular ejection fraction (LVEF) (p=<0.001). Fetal growth restriction in neonates was associated with a significant reduction in left ventricular ejection fraction compared to controls (66.14% vs 69.46%; P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: